title: Alendronate tracheobronchitis.
authors.affiliation: Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, Duke University Medical Center, Durham, NC 27617, USA. K.mahmood@duke.edu
authors.forename: Kamran
authors.initials: K
authors.lastname: Mahmood
authors.forename: Sahar
authors.initials: S
authors.lastname: Koubar
authors.forename: Scott L
authors.initials: SL
authors.lastname: Shofer
authors.forename: Neil A
authors.initials: NA
authors.lastname: Ninan
authors.forename: Momen M
authors.initials: MM
authors.lastname: Wahidi
mesh_terms: D019386:Alendronate / Q000008:administration & dosage / Q000009:adverse effects*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001706:Biopsy; D050071:Bone Density Conservation Agents / Q000008:administration & dosage / Q000009:adverse effects; D001991:Bronchitis / Q000139:chemically induced / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy; D001999:Bronchoscopy / Q000379:methods*; D003646:Debridement; D005260:Female; D006801:Humans; D008875:Middle Aged; D010024:Osteoporosis / Q000188:drug therapy; D011241:Prednisone / Q000627:therapeutic use; D012137:Respiratory System / Q000473:pathology / Q000503:physiopathology / Q000601:surgery; D014136:Tracheitis / Q000139:chemically induced / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D050071:Bone Density Conservation Agents; D011241:Prednisone; D019386:Alendronate